Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments
Alexandra Pons-Riverola, Herminio Morillas, Javier Berdejo, Sònia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Adela Fernández-Ortega, Ana Carla Oliveira, E. Martinez, Santiago Jiménez‐Marrero, Elena Pina, Eduard Fort Casamartina, Raúl Ramos-Polo, L Alcoberro, Encarnación Hidalgo, Maite Antonio-Rebollo, Laia Alcober, Cristina Enjuanes Grau, Josep Comín‐Colet, Pedro Moliner
Abstract
Cardiovascular disease is a common problem in cancer patients that is becoming more widely recognized. This may be a consequence of prior cardiovascular risk factors but could also be secondary to the anticancer treatments. With the goal of offering a multidisciplinary approach to guaranteeing optimal cancer therapy and the early detection of related cardiac diseases, and in light of the recent ESC Cardio-Oncology Guideline recommendations, we developed a Cardio-Oncology unit devoted to the prevention and management of these specific complications. This document brings together important aspects to consider for the development and organization of a Cardio-Oncology program through our own experience and the current evidence.